{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:18:43Z","timestamp":1783070323123,"version":"3.54.6"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:00Z","timestamp":1782604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271501"],"award-info":[{"award-number":["32271501"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770228"],"award-info":[{"award-number":["81770228"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shenzhen Science and Technology Plan Platform and Carrier Special Project","award":["ZDSYS20220303153551001"],"award-info":[{"award-number":["ZDSYS20220303153551001"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["BJ-2024-219"],"award-info":[{"award-number":["BJ-2024-219"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02203-6","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T19:35:48Z","timestamp":1782675348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["KIF7 promotes the proliferation of clear cell renal cell carcinoma by activating the WNT\/\u03b2-catenin signaling pathway"],"prefix":"10.1007","volume":"26","author":[{"given":"Yao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Juan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Feng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Qun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,28]]},"reference":[{"issue":"1","key":"2203_CR1","first-page":"1","volume":"2","author":"R Zheng","year":"2022","unstructured":"Zheng R, Zhang S, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2016. J Natl Cancer Cent. 2022;2(1):1\u20139.","journal-title":"J Natl Cancer Cent"},{"issue":"2","key":"2203_CR2","doi-asserted-by":"publisher","first-page":"e12668","DOI":"10.1111\/jpi.12668","volume":"69","author":"YC Wen","year":"2020","unstructured":"Wen YC, Lin YW, Chu CY, Yang YC, Yang SF, Liu YF, et al. Melatonin-triggered post-transcriptional and post-translational modifications of ADAMTS1 coordinately retard tumorigenesis and metastasis of renal cell carcinoma. J Pineal Res. 2020;69(2):e12668.","journal-title":"J Pineal Res"},{"issue":"1","key":"2203_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41420-025-02837-7","volume":"11","author":"Q Wang","year":"2025","unstructured":"Wang Q, Tang A, Zhuang Q, Xu H, Xu S, Zhang J, et al. TKT drives renal cell carcinoma progression through metabolic reprogramming and synergistic interaction with PKM2. Cell Death Discov. 2025;11(1):537.","journal-title":"Cell Death Discov"},{"issue":"1","key":"2203_CR4","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41420-025-02479-9","volume":"11","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Zhang S, Sun H, Xu L. The pathogenesis and therapeutic implications of metabolic reprogramming in renal cell carcinoma. Cell Death Discov. 2025;11(1):186.","journal-title":"Cell Death Discov"},{"issue":"1","key":"2203_CR5","doi-asserted-by":"publisher","first-page":"e2021869","DOI":"10.1001\/jamanetworkopen.2020.21869","volume":"4","author":"S Dudani","year":"2021","unstructured":"Dudani S, de Velasco G, Wells JC, Gan CL, Donskov F, Porta C, et al. Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival. JAMA Netw Open. 2021;4(1):e2021869.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2203_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41420-025-02426-8","volume":"11","author":"Y Yang","year":"2025","unstructured":"Yang Y, Ma Y, Fan S, Zhu J, Ye B, Zhang R, et al. MLN4924 suppresses tumor metabolism and growth of clear cell renal cell carcinoma by stabilizing nuclear FBP1. Cell Death Discov. 2025;11(1):253.","journal-title":"Cell Death Discov"},{"issue":"1","key":"2203_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41420-025-02380-5","volume":"11","author":"W Yang","year":"2025","unstructured":"Yang W, Wu C, Jiang C, Jing T, Lu M, Xia D, et al. FDX1 overexpression inhibits the growth and metastasis of clear cell renal cell carcinoma by upregulating FMR1 expression. Cell Death Discov. 2025;11(1):115.","journal-title":"Cell Death Discov"},{"issue":"1","key":"2203_CR8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41420-025-02766-5","volume":"11","author":"J Wang","year":"2025","unstructured":"Wang J, Luo H, He Q, Shao H, Cai X, Cao Y, et al. NCOA7 inhibits renal cancer progression by inducing autophagy and lipid metabolism through V-ATPase interaction. Cell Death Discov. 2025;11(1):471.","journal-title":"Cell Death Discov"},{"issue":"1","key":"2203_CR9","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1186\/s12967-025-07403-4","volume":"23","author":"C Dai","year":"2025","unstructured":"Dai C, Hu J, Tian X, Zhou H, Yang Z, Jin S, et al. DCST1-AS1 promotes renal cell carcinoma progression via regulating the miR-582-5p\/HMGB2 axis. J Transl Med. 2025;23(1):1352.","journal-title":"J Transl Med"},{"issue":"1","key":"2203_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41420-025-02385-0","volume":"11","author":"F Wang","year":"2025","unstructured":"Wang F, Li L, Sun X, Cai X, Wang J, Luo H, et al. The feedback loop between miR-222-3p and ZEB1 harnesses metastasis in renal cell carcinoma. Cell Death Discov. 2025;11(1):97.","journal-title":"Cell Death Discov"},{"issue":"2","key":"2203_CR11","doi-asserted-by":"publisher","first-page":"101688","DOI":"10.1016\/j.gendis.2025.101688","volume":"13","author":"W Xie","year":"2026","unstructured":"Xie W, Fu Z, Skutella T, Jiang Q, Zhang R, Zhang Y. CTHRC1 promotes the progression of clear cell renal cell carcinoma via the PI3K\/AKT\/GSK3\u03b2 signaling pathway. Genes Dis. 2026;13(2):101688.","journal-title":"Genes Dis"},{"issue":"1","key":"2203_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41420-025-02848-4","volume":"12","author":"W Yang","year":"2026","unstructured":"Yang W, Li Y, Li Z, Jiang C, Deng X, Peng D. HSP90AA1 restrains clear cell renal cell carcinoma progression by promoting CADM1 expression and suppressing the PI3K-AKT pathway through interaction with FBXO7. Cell Death Discov. 2026;12(1):6.","journal-title":"Cell Death Discov"},{"issue":"1","key":"2203_CR13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41420-025-02734-z","volume":"11","author":"S Abraham Gnanadass","year":"2025","unstructured":"Abraham Gnanadass S, Pandey S, Viswanathan P. Decoding cuproptosis and cuproplasia: implications for therapeutic strategies in renal cell carcinoma. Cell Death Discov. 2025;11(1):501.","journal-title":"Cell Death Discov"},{"issue":"1","key":"2203_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12967-025-07518-8","volume":"24","author":"HK Rachamala","year":"2025","unstructured":"Rachamala HK, Nakka NMR, Dutta SK, Wang E, Mukhopadhyay D, Pal K. Strategic trimodal therapy enhances radiation-induced abscopal response in renal cancer. J Transl Med. 2025;24(1):31.","journal-title":"J Transl Med"},{"issue":"5785","key":"2203_CR15","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/287795a0","volume":"287","author":"C N\u00fcsslein-Volhard","year":"1980","unstructured":"N\u00fcsslein-Volhard C, Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature. 1980;287(5785):795\u2013801.","journal-title":"Nature"},{"issue":"23","key":"2203_CR16","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1101\/gad.938601","volume":"15","author":"PW Ingham","year":"2001","unstructured":"Ingham PW, McMahon AP. Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 2001;15(23):3059\u201387.","journal-title":"Genes Dev"},{"issue":"3","key":"2203_CR17","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0960-9822(02)00480-3","volume":"6","author":"MJ Bitgood","year":"1996","unstructured":"Bitgood MJ, Shen L, McMahon AP. Sertoli cell signaling by Desert hedgehog regulates the male germline. Curr Biol. 1996;6(3):298\u2013304.","journal-title":"Curr Biol"},{"issue":"11","key":"2203_CR18","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1101\/gad.981202","volume":"16","author":"HH Yao","year":"2002","unstructured":"Yao HH, Whoriskey W, Capel B. Desert Hedgehog\/Patched 1 signaling specifies fetal Leydig cell fate in testis organogenesis. Genes Dev. 2002;16(11):1433\u201340.","journal-title":"Genes Dev"},{"issue":"8","key":"2203_CR19","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1210\/en.2005-0311","volume":"146","author":"M Wijgerde","year":"2005","unstructured":"Wijgerde M, Ooms M, Hoogerbrugge JW, Grootegoed JA. Hedgehog signaling in mouse ovary: Indian hedgehog and desert hedgehog from granulosa cells induce target gene expression in developing theca cells. Endocrinology. 2005;146(8):3558\u201366.","journal-title":"Endocrinology"},{"issue":"1","key":"2203_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12964-018-0220-7","volume":"16","author":"GB Carballo","year":"2018","unstructured":"Carballo GB, Honorato JR, de Lopes GPF, Spohr T. A highlight on Sonic hedgehog pathway. Cell Commun Signal. 2018;16(1):11.","journal-title":"Cell Commun Signal"},{"issue":"6","key":"2203_CR21","first-page":"5801","volume":"18","author":"A Kotulak-Chrzaszcz","year":"2019","unstructured":"Kotulak-Chrzaszcz A, Klacz J, Matuszewski M, Kmiec Z, Wierzbicki PM. Expression of the Sonic Hedgehog pathway components in clear cell renal cell carcinoma. Oncol Lett. 2019;18(6):5801\u201310.","journal-title":"Oncol Lett"},{"key":"2203_CR22","doi-asserted-by":"crossref","unstructured":"Dunatov Huljev A, Kelam N, Benzon B, \u0160olji\u0107 V, Filipovi\u0107 N, Pe\u0161uti\u0107 Pisac V et al. Expression Pattern of Sonic Hedgehog, Patched and Smoothened in Clear Cell Renal Carcinoma. Int J Mol Sci. 2023;24(10).","DOI":"10.3390\/ijms24108935"},{"key":"2203_CR23","unstructured":"Kotulak-Chrzaszcz A, Rybarczyk A, Klacz J, Matuszewski M, Kmiec Z, Wierzbicki PM. Expression levels of sonic hedgehog pathway genes and their targets are upregulated in early clear cell renal cell carcinoma. Int J Mol Med. 2022;49(5)."},{"issue":"1","key":"2203_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41420-021-00484-2","volume":"7","author":"B Han","year":"2021","unstructured":"Han B, Sun Z, Yu T, Wang Y, Kuang L, Li T, et al. SPOP-PTEN-SUFU axis promotes progression of clear cell renal cell carcinoma via activating SHH and WNT pathway. Cell Death Discov. 2021;7(1):120.","journal-title":"Cell Death Discov"},{"issue":"10","key":"2203_CR25","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nrm2774","volume":"10","author":"N Hirokawa","year":"2009","unstructured":"Hirokawa N, Noda Y, Tanaka Y, Niwa S. Kinesin superfamily motor proteins and intracellular transport. Nat Rev Mol Cell Biol. 2009;10(10):682\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"22","key":"2203_CR26","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.1002\/cncr.25461","volume":"116","author":"Y Yu","year":"2010","unstructured":"Yu Y, Feng YM. The role of kinesin family proteins in tumorigenesis and progression: potential biomarkers and molecular targets for cancer therapy. Cancer. 2010;116(22):5150\u201360.","journal-title":"Cancer"},{"key":"2203_CR27","doi-asserted-by":"publisher","first-page":"1179897","DOI":"10.3389\/fonc.2023.1179897","volume":"13","author":"M Zhong","year":"2023","unstructured":"Zhong M, Gong L, Li N, Guan H, Gong K, Zhong Y, et al. Pan-cancer analysis of kinesin family members with potential implications in prognosis and immunological role in human cancer. Front Oncol. 2023;13:1179897.","journal-title":"Front Oncol"},{"issue":"11","key":"2203_CR28","doi-asserted-by":"publisher","first-page":"7165","DOI":"10.21037\/tcr-20-1937","volume":"9","author":"C Li","year":"2020","unstructured":"Li C, Chen J, Su Z. KIF4A is a promising prognostic marker and correlates with immune infiltration in clear cell renal cell carcinoma. Transl Cancer Res. 2020;9(11):7165\u201373.","journal-title":"Transl Cancer Res"},{"issue":"5","key":"2203_CR29","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1136\/jclinpath-2018-205390","volume":"72","author":"Q Jin","year":"2019","unstructured":"Jin Q, Dai Y, Wang Y, Zhang S, Liu G. High kinesin family member 11 expression predicts poor prognosis in patients with clear cell renal cell carcinoma. J Clin Pathol. 2019;72(5):354\u201362.","journal-title":"J Clin Pathol"},{"issue":"24","key":"2203_CR30","doi-asserted-by":"publisher","first-page":"25878","DOI":"10.18632\/aging.202153","volume":"12","author":"X Ren","year":"2020","unstructured":"Ren X, Chen X, Ji Y, Li L, Li Y, Qin C, et al. Upregulation of KIF20A promotes tumor proliferation and invasion in renal clear cell carcinoma and is associated with adverse clinical outcome. Aging. 2020;12(24):25878\u201394.","journal-title":"Aging"},{"issue":"9","key":"2203_CR31","doi-asserted-by":"publisher","first-page":"16517","DOI":"10.1002\/jcp.28322","volume":"234","author":"G Li","year":"2019","unstructured":"Li G, Xie ZK, Zhu DS, Guo T, Cai QL, Wang Y. KIF20B promotes the progression of clear cell renal cell carcinoma by stimulating cell proliferation. J Cell Physiol. 2019;234(9):16517\u201325.","journal-title":"J Cell Physiol"},{"key":"2203_CR32","first-page":"1717","volume":"14","author":"X Bai","year":"2021","unstructured":"Bai X, Cao Y, Yan X, Tuoheti K, Du G, Chen Z, et al. Systematic Pan-Cancer Analysis of KIF23 and a Prediction Model Based on KIF23 in Clear Cell Renal Cell Carcinoma (ccRCC). Pharmgenomics Pers Med. 2021;14:1717\u201329.","journal-title":"Pharmgenomics Pers Med"},{"key":"2203_CR33","doi-asserted-by":"publisher","first-page":"839821","DOI":"10.3389\/fcell.2022.839821","volume":"10","author":"Z Wu","year":"2022","unstructured":"Wu Z, Song Y, Wu Y, Ge L, Liu Z, Du T, et al. Identification of KIF23 as a Prognostic Biomarker Associated With Progression of Clear Cell Renal Cell Carcinoma. Front Cell Dev Biol. 2022;10:839821.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"2203_CR34","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1007\/s12253-019-00740-y","volume":"26","author":"Q Liu","year":"2020","unstructured":"Liu Q, Zhang X, Tang H, Liu J, Fu C, Sun M, et al. Bioinformatics Analysis Suggests the Combined Expression of AURKB and KIF18B Being an Important Event in the Development of Clear Cell Renal Cell Carcinoma. Pathol Oncol Res. 2020;26(3):1583\u201394.","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"2203_CR35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3892\/etm.2016.3335","volume":"12","author":"QI Chen","year":"2016","unstructured":"Chen QI, Cao B, Nan N, Wang YU, Zhai XU, Li Y, et al. Elevated expression of KIF18A enhances cell proliferation and predicts poor survival in human clear cell renal carcinoma. Exp Ther Med. 2016;12(1):377\u201383.","journal-title":"Exp Ther Med"},{"issue":"12","key":"2203_CR36","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/s41419-020-03268-1","volume":"11","author":"Q Lv","year":"2020","unstructured":"Lv Q, Dong F, Zhou Y, Cai Z, Wang G. RNA-binding protein SORBS2 suppresses clear cell renal cell carcinoma metastasis by enhancing MTUS1 mRNA stability. Cell Death Dis. 2020;11(12):1056.","journal-title":"Cell Death Dis"},{"issue":"7","key":"2203_CR37","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/ncb2988","volume":"16","author":"M He","year":"2014","unstructured":"He M, Subramanian R, Bangs F, Omelchenko T, Liem KF Jr., Kapoor TM, et al. The kinesin-4 protein Kif7 regulates mammalian Hedgehog signalling by organizing the cilium tip compartment. Nat Cell Biol. 2014;16(7):663\u201372.","journal-title":"Nat Cell Biol"},{"issue":"32","key":"2203_CR38","doi-asserted-by":"publisher","first-page":"13377","DOI":"10.1073\/pnas.0906944106","volume":"106","author":"KF Liem Jr","year":"2009","unstructured":"Liem KF Jr., He M, Ocbina PJ, Anderson KV. Mouse Kif7\/Costal2 is a cilia-associated protein that regulates Sonic hedgehog signaling. Proc Natl Acad Sci U S A. 2009;106(32):13377\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2203_CR39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0065-230X(08)00402-8","volume":"101","author":"SY Cheng","year":"2008","unstructured":"Cheng SY, Yue S. Role and regulation of human tumor suppressor SUFU in Hedgehog signaling. Adv Cancer Res. 2008;101:29\u201343.","journal-title":"Adv Cancer Res"},{"issue":"76","key":"2203_CR40","doi-asserted-by":"publisher","first-page":"ra29","DOI":"10.1126\/scisignal.2000405","volume":"2","author":"HO Cheung","year":"2009","unstructured":"Cheung HO, Zhang X, Ribeiro A, Mo R, Makino S, Puviindran V, et al. The kinesin protein Kif7 is a critical regulator of Gli transcription factors in mammalian hedgehog signaling. Sci Signal. 2009;2(76):ra29.","journal-title":"Sci Signal"},{"issue":"17","key":"2203_CR41","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1242\/dev.069492","volume":"138","author":"SH Hsu","year":"2011","unstructured":"Hsu SH, Zhang X, Yu C, Li ZJ, Wunder JS, Hui CC, et al. Kif7 promotes hedgehog signaling in growth plate chondrocytes by restricting the inhibitory function of Sufu. Development. 2011;138(17):3791\u2013801.","journal-title":"Development"},{"issue":"11","key":"2203_CR42","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1080\/14728222.2020.1823967","volume":"24","author":"L Lospinoso Severini","year":"2020","unstructured":"Lospinoso Severini L, Ghirga F, Bufalieri F, Quaglio D, Infante P, Di Marcotullio L. The SHH\/GLI signaling pathway: a therapeutic target for medulloblastoma. Expert Opin Ther Targets. 2020;24(11):1159\u201381.","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"2203_CR43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11934-015-0568-9","volume":"17","author":"IS Syed","year":"2016","unstructured":"Syed IS, Pedram A, Farhat WA. Role of Sonic Hedgehog (Shh) Signaling in Bladder Cancer Stemness and Tumorigenesis. Curr Urol Rep. 2016;17(2):11.","journal-title":"Curr Urol Rep"},{"issue":"3","key":"2203_CR44","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s12032-015-0492-3","volume":"32","author":"AA Samadani","year":"2015","unstructured":"Samadani AA, Akhavan-Niaki H. Interaction of sonic hedgehog (SHH) pathway with cancer stem cell genes in gastric cancer. Med Oncol. 2015;32(3):48.","journal-title":"Med Oncol"},{"issue":"11","key":"2203_CR45","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1002\/pros.22830","volume":"74","author":"M Statkiewicz","year":"2014","unstructured":"Statkiewicz M, Maryan N, Lipiec A, Grecka E, Grygorowicz MA, Omiotek M, et al. The role of the SHH gene in prostate cancer cell resistance to paclitaxel. Prostate. 2014;74(11):1142\u201352.","journal-title":"Prostate"},{"issue":"7","key":"2203_CR46","doi-asserted-by":"publisher","first-page":"9943","DOI":"10.1007\/s13277-016-4898-0","volume":"37","author":"H Gan","year":"2016","unstructured":"Gan H, Liu H, Zhang H, Li Y, Xu X, Xu X, et al. SHh-Gli1 signaling pathway promotes cell survival by mediating baculoviral IAP repeat-containing 3 (BIRC3) gene in pancreatic cancer cells. Tumour Biol. 2016;37(7):9943\u201350.","journal-title":"Tumour Biol"},{"issue":"1","key":"2203_CR47","doi-asserted-by":"publisher","first-page":"6620","DOI":"10.1038\/s41598-019-43093-x","volume":"9","author":"SK Riaz","year":"2019","unstructured":"Riaz SK, Ke Y, Wang F, Kayani MA, Malik MFA. Influence of SHH\/GLI1 axis on EMT mediated migration and invasion of breast cancer cells. Sci Rep. 2019;9(1):6620.","journal-title":"Sci Rep"},{"issue":"1","key":"2203_CR48","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12943-022-01616-7","volume":"21","author":"H Zhao","year":"2022","unstructured":"Zhao H, Ming T, Tang S, Ren S, Yang H, Liu M, et al. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Mol Cancer. 2022;21(1):144.","journal-title":"Mol Cancer"},{"issue":"6","key":"2203_CR49","first-page":"6327","volume":"14","author":"M Ding","year":"2017","unstructured":"Ding M, Wang X. Antagonism between Hedgehog and Wnt signaling pathways regulates tumorigenicity. Oncol Lett. 2017;14(6):6327\u201333.","journal-title":"Oncol Lett"},{"key":"2203_CR50","doi-asserted-by":"crossref","unstructured":"Lang CMR, Chan CK, Veltri A, Lien WH. Wnt Signaling Pathways in Keratinocyte Carcinomas. Cancers (Basel). 2019;11(9).","DOI":"10.3390\/cancers11091216"},{"issue":"1","key":"2203_CR51","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/jdb5010002","volume":"5","author":"NR Zu\u00f1iga","year":"2017","unstructured":"Zu\u00f1iga NR, Stoeckli ET. Sonic Hedgehog\u2014\u2018Jack-of-All-Trades\u2019 in Neural Circuit Formation. J Dev Biology. 2017;5(1):2.","journal-title":"J Dev Biology"},{"issue":"1","key":"2203_CR52","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1038\/s41598-018-23212-w","volume":"8","author":"J Masannat","year":"2018","unstructured":"Masannat J, Purayil HT, Zhang Y, Russin M, Mahmud I, Kim W, et al. \u03b2Arrestin2 Mediates Renal Cell Carcinoma Tumor Growth. Sci Rep. 2018;8(1):4879.","journal-title":"Sci Rep"},{"issue":"6","key":"2203_CR53","first-page":"330","volume":"109","author":"YC Lin","year":"2024","unstructured":"Lin YC, Sun DP, Hsieh TH, Chen CH. Targeting CK1\u03b4 and CK1\u03b5 as a New Therapeutic Approach for Clear Cell Renal Cell Carcinoma. Pharmacology. 2024;109(6):330\u201340.","journal-title":"Pharmacology"},{"issue":"9","key":"2203_CR54","doi-asserted-by":"publisher","first-page":"101189","DOI":"10.1016\/j.xcrm.2023.101189","volume":"4","author":"J Nyman","year":"2023","unstructured":"Nyman J, Denize T, Bakouny Z, Labaki C, Titchen BM, Bi K, et al. Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer states. Cell Rep Med. 2023;4(9):101189.","journal-title":"Cell Rep Med"},{"issue":"3","key":"2203_CR55","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1172\/JCI60818","volume":"122","author":"N Taira","year":"2012","unstructured":"Taira N, Mimoto R, Kurata M, Yamaguchi T, Kitagawa M, Miki Y, et al. DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells. J Clin Invest. 2012;122(3):859\u201372.","journal-title":"J Clin Invest"},{"issue":"5","key":"2203_CR56","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1101\/gad.13.5.607","volume":"13","author":"M Schreiber","year":"1999","unstructured":"Schreiber M, Kolbus A, Piu F, Szabowski A, M\u00f6hle-Steinlein U, Tian J, et al. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev. 1999;13(5):607\u201319.","journal-title":"Genes Dev"},{"issue":"2","key":"2203_CR57","doi-asserted-by":"publisher","first-page":"107","DOI":"10.32725\/jab.2024.014","volume":"22","author":"Z Yan","year":"2024","unstructured":"Yan Z, Zhong Q, Yan L, Lai W, Xu X. Ethyl pyruvate attenuates cellular adhesion and proliferation of diffuse large B-cell lymphoma by targeting c-Jun. J Appl Biomed. 2024;22(2):107\u201314.","journal-title":"J Appl Biomed"},{"key":"2203_CR58","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1471-2407-7-145","volume":"7","author":"Y Zhang","year":"2007","unstructured":"Zhang Y, Pu X, Shi M, Chen L, Song Y, Qian L, et al. Critical role of c-Jun overexpression in liver metastasis of human breast cancer xenograft model. BMC Cancer. 2007;7:145.","journal-title":"BMC Cancer"},{"key":"2203_CR59","doi-asserted-by":"crossref","unstructured":"Elbadawy M, Usui T, Yamawaki H, Sasaki K. Emerging Roles of C-Myc in Cancer Stem Cell-Related Signaling and Resistance to Cancer Chemotherapy: A Potential Therapeutic Target Against Colorectal Cancer. Int J Mol Sci. 2019;20(9).","DOI":"10.3390\/ijms20092340"},{"key":"2203_CR60","doi-asserted-by":"publisher","first-page":"111709","DOI":"10.1016\/j.cellsig.2025.111709","volume":"131","author":"B Li","year":"2025","unstructured":"Li B, Liu T, Zhao M, Guo D, Peng W, Tao Z, et al. MYC amplification sensitizes TNBC to CHK1 inhibitors. Cell Signal. 2025;131:111709.","journal-title":"Cell Signal"},{"issue":"6","key":"2203_CR61","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1128\/MCB.22.6.1819-1833.2002","volume":"22","author":"JH Sheen","year":"2002","unstructured":"Sheen JH, Dickson RB. Overexpression of c-Myc alters G(1)\/S arrest following ionizing radiation. Mol Cell Biol. 2002;22(6):1819\u201333.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"2203_CR62","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/s41467-024-45760-8","volume":"15","author":"A Gaballa","year":"2024","unstructured":"Gaballa A, Gebhardt-Wolf A, Krenz B, Mattavelli G, John M, Cossa G, et al. PAF1c links S-phase progression to immune evasion and MYC function in pancreatic carcinoma. Nat Commun. 2024;15(1):1446.","journal-title":"Nat Commun"},{"issue":"1","key":"2203_CR63","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41420-025-02503-y","volume":"11","author":"DM Xu","year":"2025","unstructured":"Xu DM, Chen LX, Xue T, Zhuang XY, Wei LC, Han H, et al. Decoding the impact of MMP1\u2009+\u2009malignant subsets on tumor-immune interactions: insights from single-cell and spatial transcriptomics. Cell Death Discov. 2025;11(1):244.","journal-title":"Cell Death Discov"},{"issue":"1","key":"2203_CR64","doi-asserted-by":"publisher","first-page":"101771","DOI":"10.1016\/j.gendis.2025.101771","volume":"13","author":"C Liu","year":"2026","unstructured":"Liu C, Wang S, Zhang X, Han Y, Tan M, Fan J, et al. The biomechanical signature of tumor invasion. Genes Dis. 2026;13(1):101771.","journal-title":"Genes Dis"},{"issue":"1","key":"2203_CR65","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s12967-025-06596-y","volume":"23","author":"Q Wang","year":"2025","unstructured":"Wang Q, Feng W, Tan Y, Qiao J, Liu H, Liu Q, et al. Antiphospholipid antibodies inhibit the migration and invasion of trophoblast cells by suppressing the JNK\/C-Jun\/MMP1 signaling pathway. J Transl Med. 2025;23(1):581.","journal-title":"J Transl Med"},{"issue":"5","key":"2203_CR66","doi-asserted-by":"publisher","first-page":"101529","DOI":"10.1016\/j.gendis.2025.101529","volume":"12","author":"S Tian","year":"2025","unstructured":"Tian S, Chen X, Li J. Zinc finger transcription factor ZNF24 inhibits colorectal cancer growth and metastasis by suppressing MMP2 transcription. Genes Dis. 2025;12(5):101529.","journal-title":"Genes Dis"},{"issue":"1","key":"2203_CR67","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41420-024-01962-z","volume":"10","author":"P Xing","year":"2024","unstructured":"Xing P, Liu H, Xiao W, Zhang G, Zhang C, Liao Z, et al. The fusion gene LRP1-SNRNP25 drives invasion and migration by activating the pJNK\/37LRP\/MMP2 signaling pathway in osteosarcoma. Cell Death Discov. 2024;10(1):198.","journal-title":"Cell Death Discov"},{"issue":"1","key":"2203_CR68","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41420-025-02536-3","volume":"11","author":"Z Wang","year":"2025","unstructured":"Wang Z, Sun H, Zhu S, Wang F, Li Q, Zhou J. RGS3 acts as a tumor promoter by facilitating the regulation of the TGF-\u03b2 signaling pathway and promoting EMT in ovarian cancer. Cell Death Discov. 2025;11(1):262.","journal-title":"Cell Death Discov"},{"issue":"7","key":"2203_CR69","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1158\/1078-0432.CCR-20-3715","volume":"27","author":"NG Steele","year":"2021","unstructured":"Steele NG, Biffi G, Kemp SB, Zhang Y, Drouillard D, Syu L, et al. Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer. Clin Cancer Res. 2021;27(7):2023\u201337.","journal-title":"Clin Cancer Res"},{"key":"2203_CR70","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","volume":"470","author":"X Lei","year":"2020","unstructured":"Lei X, Lei Y, Li JK, Du WX, Li RG, Yang J, et al. Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy. Cancer Lett. 2020;470:126\u201333.","journal-title":"Cancer Lett"},{"issue":"1","key":"2203_CR71","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.yexcr.2017.12.026","volume":"363","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wang Y, Xu L, Lu X, Fu D, Su J, et al. CD4\u2009+\u2009T cells promote renal cell carcinoma proliferation via modulating YBX1. Exp Cell Res. 2018;363(1):95\u2013101.","journal-title":"Exp Cell Res"},{"key":"2203_CR72","doi-asserted-by":"publisher","first-page":"1514578","DOI":"10.3389\/fonc.2024.1514578","volume":"14","author":"R Wu","year":"2024","unstructured":"Wu R, Zeng M, Zhang Y, He J. LAG3 immune inhibitors: a novel strategy for melanoma treatment. Front Oncol. 2024;14:1514578.","journal-title":"Front Oncol"},{"key":"2203_CR73","doi-asserted-by":"publisher","first-page":"1309055","DOI":"10.3389\/fimmu.2023.1309055","volume":"14","author":"H Zhang","year":"2023","unstructured":"Zhang H, Hu Y, Wu T, Chen Y, Yang B, Xie T. Clinical characteristics and novel strategies of immune checkpoint inhibitor rechallenge therapy for non-small cell lung cancer: a comprehensive review. Front Immunol. 2023;14:1309055.","journal-title":"Front Immunol"},{"issue":"4","key":"2203_CR74","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41571-020-00455-z","volume":"18","author":"DA Braun","year":"2021","unstructured":"Braun DA, Bakouny Z, Hirsch L, Flippot R, Van Allen EM, Wu CJ, et al. Beyond conventional immune-checkpoint inhibition - novel immunotherapies for renal cell carcinoma. Nat Rev Clin Oncol. 2021;18(4):199\u2013214.","journal-title":"Nat Rev Clin Oncol"},{"key":"2203_CR75","doi-asserted-by":"publisher","first-page":"104225","DOI":"10.1016\/j.critrevonc.2023.104225","volume":"193","author":"S Ebrahimi","year":"2024","unstructured":"Ebrahimi S, Habibzadeh A, Khojasteh-Kaffash S, Valizadeh P, Samieefar N, Rezaei N. Immune checkpoint inhibitors therapy as the game-changing approach for pediatric lymphoma: A brief landscape. Crit Rev Oncol Hematol. 2024;193:104225.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"2203_CR76","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1080\/21645515.2019.1571892","volume":"15","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Chen M, Nie H, Yuan Y. PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations. Hum Vaccin Immunother. 2019;15(5):1111\u201322.","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"2203_CR77","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.molcel.2019.09.030","volume":"76","author":"JH Cha","year":"2019","unstructured":"Cha JH, Chan LC, Li CW, Hsu JL, Hung MC. Mechanisms Controlling PD-L1 Expression in Cancer. Mol Cell. 2019;76(3):359\u201370.","journal-title":"Mol Cell"},{"key":"2203_CR78","doi-asserted-by":"crossref","unstructured":"Han TD, Shang DH, Tian Y. Docetaxel enhances apoptosis and G2\/M cell cycle arrest by suppressing mitogen-activated protein kinase signaling in human renal clear cell carcinoma. Genet Mol Res. 2016;15(1).","DOI":"10.4238\/gmr.15017321"},{"key":"2203_CR79","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.canlet.2017.02.021","volume":"394","author":"AS Leal","year":"2017","unstructured":"Leal AS, Williams CR, Royce DB, Pioli PA, Sporn MB, Liby KT. Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer. Cancer Lett. 2017;394:76\u201387.","journal-title":"Cancer Lett"},{"issue":"1","key":"2203_CR80","doi-asserted-by":"publisher","first-page":"8102","DOI":"10.1038\/s41598-018-26496-0","volume":"8","author":"F Xie","year":"2018","unstructured":"Xie F, Huang M, Lin X, Liu C, Liu Z, Meng F, et al. The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine. Sci Rep. 2018;8(1):8102.","journal-title":"Sci Rep"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02203-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02203-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02203-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T08:47:21Z","timestamp":1783068441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02203-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,28]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2203"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02203-6","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,28]]},"assertion":[{"value":"6 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Part of the experimental data in this study was obtained from Shanghai OUTDO Biotech Co., Ltd. and approved by its Ethics Committee (Approval No.: SHYJS-CP-1707003). In addition, publicly available and fully de-identified data from The Cancer Genome Atlas (TCGA) were used, and all analyses complied with the human subject protection and data access policies outlined by the National Cancer Institute and NHGRI (January 2014). All data were analyzed in accordance with relevant ethical standards and data-use policies to ensure compliance, safety, and traceability throughout the research process.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}}],"article-number":"246"}}